Publications & Patents

Publications

2023

Abu Bakar NDB, Carlessi R, Gogoi-Tiwari J, Köhn-Gaone J, Williams V, Falasca M, Olynyk JK, Ramm GA, Tirnitz-Parker JEE. TWEAK/Fn14 Signalling Regulates the Tissue Microenvironment in Chronic Pancreatitis. Cancers (Basel). 2023 Mar 16;15(6):1807.

De Giorgis V, Barberis E, Falasca M and Manfredi M. In-Depth Proteomic Analysis of Blood Circulating Small Extracellular Vesicles. Methods in Molecular Biology, 2023 2628:279-289.

Fyfe J, Malhotra P and Falasca M. Modified lipidomic profile of cancer-associated Small Extracellular Vesicles facilitates tumorigenic behaviours and contributes to disease progression. Advances in Biological Regulation, 2023 Jan; 87:100935.

2022

Selvaggi F, Melchiorre E, Casari I, Cinalli S, Cinalli M, Aceto GA, Cotellese R, Garajova I and Falasca M. Perineural Invasion in Pancreatic Ductal Adenocarcinoma: from Molecules towards Drugs of Clinical Relevance. Cancers, 2022 Nov 24; 14(23):5793.

Barberis E, Khoso S, Sica A, Falasca M, Gennari A, Dondero F, Afantitis A, Manfredi M. Precision Medicine Approaches with Metabolomics and Artificial Intelligence. Int J Mol Sci. 2022 Sep 24;23(19):11269.


Lee YT, Tan YJ, Mok PY, Kaur G, Sreenivasan S, Falasca M, Oon CE. Sex-divergent expression of cytochrome P450 and SIRTUIN 1-7 proteins in toxicity evaluation of a benzimidazole-derived epigenetic modulator in mice.
Toxicol Appl Pharmacol. 2022 Jun 15;445:116039.

Falasca V, Falasca M. Targeting the Endocannabinoidome in Pancreatic Cancer. Biomolecules. 2022 Feb 17;12(2):320.

Casari I, Emmanouilidi A, Domenichini A, Falasca M. Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine. Adv Biol Regul. 2022 Jan;83:100857.

Lian J, Casari I, Falasca M. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract. Pharmacol Res. 2022 Jan;175:106025.

2021


Manfredi M, Williams E, Cho WC, Falasca M. Editorial: Recent Advances in In Vitro and In Vivo Multi-Omics Analyses of Extracellular Vesicles: Therapeutic Targets and Biomarkers.
Front Mol Biosci. 2021 Oct 27;8:784436.

Perera CJ, Falasca M, Chari ST, Greenfield JR, Xu Z, Pirola RC, Wilson JS, Apte MV. Role of Pancreatic Stellate Cell-Derived Exosomes in Pancreatic Cancer-Related Diabetes: A Novel Hypothesis. Cancers (Basel). 2021 Oct 18;13(20):5224.

Malhotra P, Palanisamy R, Falasca M. Targeting pancreatic ductal adenocarcinoma: New therapeutic options for the ongoing battle. Hepatobiliary Pancreat Dis Int. 2022 Feb;21(1):4-

2020

Journal Articles (Research)

2019

Journal Articles (Research)

2018

Journal Articles (Research)

2017

Journal Articles (Research)

2016

Journal Articles (Research)

2015

Journal Articles (Research)

2014

Journal Articles (Research)

2013

Journal Articles (Research)

2012

Journal Articles (Research)

2011

Journal Articles (Research)

2010

Journal Articles (Research)

Conference Articles (Research)

2009

Journal Articles (Research)

2008

Book Chapters (Research)

Journal Articles (Research)

2007

Journal Articles (Research)

2005

Journal Articles (Research)

2004

Journal Articles (Research)

Conference Articles (Research)

  • Falasca, M., and T. Maffucci. 2004. “Phosphatidylinositol-3-phosphate, a new crucial player in insulin signalling, is generated via a TC10-mediated phosphoinositide 3-kinase C2alpha activation.” In 40th Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Sep 5, 2004, Munich, GERMANY: SPRINGER.
  • Falasca, M. 2004. “INHIBITION OF THE PI 3-K/AKT PATHWAY BY INOSITOL PENTAKISPHOSPHATE RESULTS IN PROAPOPTOTIC AND ANTI-ANGIOGENIC EFFECTS IN VITRO AND IN VIVO.”: INT INST ANTICANCER RESEARCH.

2003

Journal Articles (Research)

2002

Journal Articles (Research)

2001

Journal Articles (Research)

Conference Articles (Research)

  • Innominato, P. F., M. A. Mariggio’, E. Piccolo, T. Maffucci, S. Iacobelli, and M. Falasca. 2001. “The mechanism involved in the regulation of PLC gamma 1 activity in cell migration.”: AMER ASSOC CANCER RESEARCH.

2000

Journal Articles (Research)

1998

Journal Articles (Research)

1997

Journal Articles (Research)

1996

Journal Articles (Research)

Conference Articles (Research)

  • Corda, D., and M. Falasca. 1996. “Glycerophosphoinositols as potential markers of ras-induced transformation and novel second messengers.”
  • Corda, D., and M. Falasca. 1996. “Glycerophosphoinositols as potential markers of ras-induced transformation and novel second messengers.” In Symposium on Lipid Metabolism and Function in Cancer – Significance of Magnetic Resonance Spectroscopy (MRS) Measurements in Relation to Biochemical Processes and Cellular Control, at the 5th International Conference of Anticancer Research, Oct 18, 1995, CORFU, GREECE: INT INST ANTICANCER RESEARCH.

1995

Journal Articles (Research)

1994

Journal Articles (Research)

1993

Journal Articles (Research)

  • Iacovelli, L., M. Falasca, S. Valitutti, D. D’Arcangelo, and D. Corda. 1993. “Glycerophosphoinositol 4-phosphate, a putative endogenous inhibitor of adenylylcyclase.” Journal of Biological Chemistry 268 (27): 20402-20407.

1992

Journal Articles (Research)

Conference Articles (Research)

1991

Journal Articles (Research)

Conference Articles (Research)

1990

Journal Articles (Research)

PATENTS

• Novel inositol phosphate derivatives. Marco Falasca, Andrew Michael Riley, Himali Yasmin Godage, Barry Victor Lloyd Potter. WO 2011064559 A3 2011

• PCT Int. Appl. (2018), WO 2018170553 A1 20180927; M. Massi, P. V. Simpson, M. Falasca: “Complexes and uses thereof”, describing the use of organometallic rhenium complexes as anticancer agents.

• PCT/AU2018/050941; P. Simpson, M. Massi, M. Falasca: “Synthetic derivatives of oleoyllysophosphatidylinositol (oleoyl-LPI) and uses thereof”, describing the use of synthetic analogues of oleyl-LPIas agonist for the GPR119 receptor.